BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 24524785)

  • 1. Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton's jelly: a critical parameter to consider in a therapeutic context.
    Reppel L; Margossian T; Yaghi L; Moreau P; Mercier N; Leger L; Hupont S; Stoltz JF; Bensoussan D; Huselstein C
    Curr Stem Cell Res Ther; 2014; 9(4):306-18. PubMed ID: 24524785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
    Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
    Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.
    Drela K; Lech W; Figiel-Dabrowska A; Zychowicz M; Mikula M; Sarnowska A; Domanska-Janik K
    Cytotherapy; 2016 Apr; 18(4):497-509. PubMed ID: 26971678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.
    Ranjbaran H; Abediankenari S; Mohammadi M; Jafari N; Khalilian A; Rahmani Z; Momeninezhad Amiri M; Ebrahimi P
    Acta Med Iran; 2018 Jan; 56(1):28-33. PubMed ID: 29436792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving stemness and functional features of mesenchymal stem cells from Wharton's jelly of a human umbilical cord by mimicking the native, low oxygen stem cell niche.
    Obradovic H; Krstic J; Trivanovic D; Mojsilovic S; Okic I; Kukolj T; Ilic V; Jaukovic A; Terzic M; Bugarski D
    Placenta; 2019 Jul; 82():25-34. PubMed ID: 31174623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Platelet Lysate Supports Efficient Expansion and Stability of Wharton's Jelly Mesenchymal Stromal Cells via Active Uptake and Release of Soluble Regenerative Factors.
    Cañas-Arboleda M; Beltrán K; Medina C; Camacho B; Salguero G
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32877987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Wharton's jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment.
    Cabrera-Pérez R; Ràfols-Mitjans A; Roig-Molina Á; Beltramone S; Vives J; Batlle-Morera L
    J Transl Med; 2023 Nov; 21(1):802. PubMed ID: 37950242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DMSO- and Serum-Free Cryopreservation of Wharton's Jelly Tissue Isolated From Human Umbilical Cord.
    Shivakumar SB; Bharti D; Subbarao RB; Jang SJ; Park JS; Ullah I; Park JK; Byun JH; Park BW; Rho GJ
    J Cell Biochem; 2016 Oct; 117(10):2397-412. PubMed ID: 27038129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells.
    Lee S; Park BJ; Kim JY; Jekarl D; Choi HY; Lee SY; Kim M; Kim Y; Park MS
    Cytotherapy; 2015 Dec; 17(12):1723-31. PubMed ID: 26589753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
    Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
    BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
    Tantrawatpan C; Manochantr S; Kheolamai P; U-Pratya Y; Supokawej A; Issaragrisil S
    J Med Assoc Thai; 2013 Sep; 96(9):1208-17. PubMed ID: 24163998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
    Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
    Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34
    Zhao D; Liu L; Chen Q; Wang F; Li Q; Zeng Q; Huang J; Luo M; Li W; Zheng Y; Liu T
    Stem Cell Res Ther; 2018 Jun; 9(1):158. PubMed ID: 29895317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells.
    Corotchi MC; Popa MA; Remes A; Sima LE; Gussi I; Lupu Plesu M
    Stem Cell Res Ther; 2013 Jul; 4(4):81. PubMed ID: 23845279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological characteristics of wharton's jelly derived mesenchymal stem cells after cryopreservation].
    Shen JL; Gong LZ; Cen J; Liu Y; Wang LX; Yin WJ; Zhao DF; Ma WN; Huang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):181-7. PubMed ID: 23484716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteogenic commitment of Wharton's jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application.
    Cabrera-Pérez R; Monguió-Tortajada M; Gámez-Valero A; Rojas-Márquez R; Borràs FE; Roura S; Vives J
    Stem Cell Res Ther; 2019 Nov; 10(1):356. PubMed ID: 31779673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.
    Raicevic G; Najar M; Pieters K; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Tissue Eng Part A; 2012 Jul; 18(13-14):1410-8. PubMed ID: 22429150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells.
    Balasubramanian S; Venugopal P; Sundarraj S; Zakaria Z; Majumdar AS; Ta M
    Cytotherapy; 2012 Jan; 14(1):26-33. PubMed ID: 22091833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Umbilical cord-derived mesenchymal stromal cells: predictive obstetric factors for cell proliferation and chondrogenic differentiation.
    Avercenc-Léger L; Guerci P; Virion JM; Cauchois G; Hupont S; Rahouadj R; Magdalou J; Stoltz JF; Bensoussan D; Huselstein C; Reppel L
    Stem Cell Res Ther; 2017 Jul; 8(1):161. PubMed ID: 28676126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.